Xue Ding

1.4k total citations · 1 hit paper
47 papers, 1.0k citations indexed

About

Xue Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xue Ding has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Xue Ding's work include Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Xue Ding is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Xue Ding collaborates with scholars based in China, United States and United Kingdom. Xue Ding's co-authors include Yun Luo, Xing Feng, Huiwen Song, Zhiyong Zhang, Meihua Lin, Shu-Jing Wu, Juan Huang, Heng Zhang, Yongxiang Zhao and Junfei Jin and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Xue Ding

44 papers receiving 1.0k citations

Hit Papers

METTL3 and ALKBH5 oppositely regulate m6A modification of... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Ding China 15 619 279 181 145 101 47 1.0k
Jianan Wang China 19 600 1.0× 272 1.0× 74 0.4× 68 0.5× 50 0.5× 55 926
Xiaokan Zhang United States 15 744 1.2× 227 0.8× 91 0.5× 71 0.5× 181 1.8× 22 974
Xian Jin China 14 569 0.9× 229 0.8× 148 0.8× 147 1.0× 159 1.6× 31 1.1k
Ruisheng Song United States 9 920 1.5× 223 0.8× 109 0.6× 123 0.8× 221 2.2× 15 1.2k
Yuting Tang China 19 757 1.2× 336 1.2× 69 0.4× 98 0.7× 67 0.7× 65 1.1k
Lu Gao China 20 599 1.0× 135 0.5× 183 1.0× 171 1.2× 246 2.4× 63 1.2k
Wen Jin China 17 657 1.1× 428 1.5× 197 1.1× 115 0.8× 121 1.2× 33 1.1k
Xiaowei Mao China 19 352 0.6× 212 0.8× 85 0.5× 91 0.6× 65 0.6× 58 1.0k
Béatrice Jaspard‐Vinassa France 24 631 1.0× 135 0.5× 307 1.7× 96 0.7× 198 2.0× 35 1.3k

Countries citing papers authored by Xue Ding

Since Specialization
Citations

This map shows the geographic impact of Xue Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Ding more than expected).

Fields of papers citing papers by Xue Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Ding. The network helps show where Xue Ding may publish in the future.

Co-authorship network of co-authors of Xue Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Ding. A scholar is included among the top collaborators of Xue Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Ding. Xue Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mi, Ping, Chunxue Wang, Miao Lu, et al.. (2025). The Role of the Hexosamine-Sialic Acid Metabolic Pathway Mediated by GFPT1/NANS in c-Myc-Driven Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 19(9). 101523–101523. 1 indexed citations
2.
Yang, Qiao, et al.. (2025). Cross sectional pilot study on clinical review generation using large language models. npj Digital Medicine. 8(1). 170–170. 1 indexed citations
3.
Ding, Xue, Yue Zhang, Régis L. Corrêa, et al.. (2024). Euphorbiaceae superoxide dismutase, catalase, and glutathione peroxidase as clues to better comprehend high drought tolerance in castor bean. Industrial Crops and Products. 222. 119510–119510. 2 indexed citations
4.
Xiong, Wei, Zhenlu Wang, Lei Gan, et al.. (2024). Total Length–Weight Relationships and Condition Factor of Invasive Procambarus clarkii (Girard, 1852) in Caohai Lake, China. Journal of Applied Ichthyology. 2024(1).
5.
6.
Wang, Yu, et al.. (2022). High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients. Journal of Neurosurgical Sciences. 66(3). 228–233. 2 indexed citations
9.
Ragab, Ahmed, Jianrong Wu, Xue Ding, et al.. (2020). 68Ga-DOTATATE PET/CT: The Optimum Standardized Uptake Value (SUV) Internal Reference. Academic Radiology. 29(1). 95–106. 5 indexed citations
10.
Ding, Xue, et al.. (2019). CDHR5 inhibits proliferation of hepatocellular carcinoma and predicts clinical prognosis. Irish Journal of Medical Science (1971 -). 189(2). 439–447. 10 indexed citations
11.
Ding, Xue, Zhouling Xie, Qi Zhao, et al.. (2016). A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin αIIbβ3. BioMed Research International. 2016. 1–8. 4 indexed citations
12.
Liu, Xuan, Caihui Wang, Xue Ding, et al.. (2016). A novel selective inhibitor to thrombin-induced platelet aggregation purified from the leech Whitmania pigra. Biochemical and Biophysical Research Communications. 473(1). 349–354. 31 indexed citations
13.
Xie, Zhouling, Lulu Zhao, Xue Ding, et al.. (2016). Design, synthesis and evaluation of novel 2-amino-3-(naphth-2-yl)propanoic acid derivatives as potent inhibitors of platelet aggregation. European Journal of Medicinal Chemistry. 125. 197–209. 3 indexed citations
14.
Chen, Yahui, et al.. (2016). Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling. Biochemical and Biophysical Research Communications. 473(1). 283–289. 15 indexed citations
15.
Ding, Xue, Chengyuan Yu, Yang Liu, et al.. (2016). Chronic obstructive sleep apnea accelerates pulmonary remodeling via TGF-β/miR-185/CoLA1 signaling in a canine model. Oncotarget. 7(36). 57545–57555. 19 indexed citations
16.
Liu, Lei, Hongwei Zhao, Fengxiang Yun, et al.. (2015). Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway. Cellular Physiology and Biochemistry. 36(5). 2039–2050. 9 indexed citations
17.
Jiang, Nan, et al.. (2014). Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer. European Journal of Surgical Oncology. 41(3). 315–322. 14 indexed citations
18.
Zhao, Jing, Wei Xu, Fengxiang Yun, et al.. (2014). Chronic obstructive sleep apnea causes atrial remodeling in canines: mechanisms and implications. Basic Research in Cardiology. 109(5). 427–427. 43 indexed citations
19.
Guo, Nan, Fayu Liu, Liangliang Yang, et al.. (2014). Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9. Oncology Reports. 32(2). 794–800. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026